XML 42 R32.htm IDEA: XBRL DOCUMENT
v3.24.3

Net Income (Loss) Per Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Earnings Per Share [Abstract] |
Schedule of Weighted Average Number of Shares | The following table presents a reconciliation of weighted-average shares outstanding used in the calculation of basic and diluted net income (loss) per share:
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2024 |  | 2023 |  | 2024 |  | 2023
Weighted-average shares outstanding: |  |  |  |  |  |  |  |
Weighted-average number of shares of common stock used in computing net income (loss) per share attributable to common stockholders—basic |  | 146,436,167 |  |  | 142,837,120 |  |  | 145,563,220 |  |  | 142,246,586 |
Dilutive effect of share equivalents resulting from stock options |  | 1,641,946 |  |  | 3,207,854 |  |  | 1,925,296 |  |  | — |
Dilutive effect of share equivalents resulting from restricted stock units |  | 1,348,552 |  |  | 225,654 |  |  | 1,164,507 |  |  | — |
Weighted-average number of shares of common stock used in computing net income (loss) per share attributable to common stockholders—diluted |  | 149,426,665 |  |  | 146,270,628 |  |  | 148,653,023 |  |  | 142,246,586 |
Schedule of Potentially Dilutive Common Stock Equivalents | The following potentially dilutive common stock equivalents, including stock options and restricted stock units, have been excluded from the calculation of diluted weighted-average shares outstanding for the three and nine months ended September 30, 2024 and 2023 because to do so would have been anti-dilutive for the periods presented:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Stock options outstanding | 1,535,122 |  |  | 4,452,615 |  |  | 2,457,405 |  |  | 8,175,646 |
Unvested RSUs and PSUs | 28,094 |  |  | 1,779,298 |  |  | 606,029 |  |  | 2,635,840 |
| 1,563,216 |  |  | 6,231,913 |  |  | 3,063,434 |  |  | 10,811,486 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration